Cancer nanovaccines: mechanisms, design principles, and clinical translation (2025)
Source: ACS Nano. Unidade: IFSC
Subjects: NEOPLASIAS, PLANEJAMENTO DE FÁRMACOS, ONCOLOGIA, NANOPARTÍCULAS, NANOTECNOLOGIA
ABNT
ZACCARIOTTO, Gabriel de Camargo et al. Cancer nanovaccines: mechanisms, design principles, and clinical translation. ACS Nano, v. 19, n. 17, p. 16204-16223, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsnano.4c15765. Acesso em: 23 maio 2025.APA
Zaccariotto, G. de C., Bistaffa, M. J., Zapata, A. M. M., Rodero, C. F., Coelho, F., Quitiba, J. V. B., et al. (2025). Cancer nanovaccines: mechanisms, design principles, and clinical translation. ACS Nano, 19( 17), 16204-16223. doi:10.1021/acsnano.4c15765NLM
Zaccariotto G de C, Bistaffa MJ, Zapata AMM, Rodero CF, Coelho F, Quitiba JVB, Lima LLP de, Sterman RG, Cardoso VM de O, Zucolotto V. Cancer nanovaccines: mechanisms, design principles, and clinical translation [Internet]. ACS Nano. 2025 ; 19( 17): 16204-16223.[citado 2025 maio 23 ] Available from: https://doi.org/10.1021/acsnano.4c15765Vancouver
Zaccariotto G de C, Bistaffa MJ, Zapata AMM, Rodero CF, Coelho F, Quitiba JVB, Lima LLP de, Sterman RG, Cardoso VM de O, Zucolotto V. Cancer nanovaccines: mechanisms, design principles, and clinical translation [Internet]. ACS Nano. 2025 ; 19( 17): 16204-16223.[citado 2025 maio 23 ] Available from: https://doi.org/10.1021/acsnano.4c15765